These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 22478720)

  • 1. MS: Prevalence, Economics, and the Pipeline.
    Butcher L
    Biotechnol Healthc; 2008 Sep; 5(3):6-7. PubMed ID: 22478720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solid tumors: prevalence, economics, and implications for payers and purchasers.
    Butcher L
    Biotechnol Healthc; 2008 May; 5(1):20-1. PubMed ID: 22478697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rheumatoid arthritis: prevalence, economics, and implications for payers and purchasers.
    Butcher L
    Biotechnol Healthc; 2008 Jul; 5(2):16-7. PubMed ID: 22478708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Digestive diseases: epidemiology, economics, and the pipeline.
    Butcher L
    Biotechnol Healthc; 2008 Nov; 5(4):12-3. PubMed ID: 22478735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resource-based relative-value scale expansion: implications for performance and quality of care.
    Burge RT
    Clin Perform Qual Health Care; 1997; 5(1):5-10. PubMed ID: 10165000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive Health Care Economics Curriculum and Training in Radiology Residency.
    Keiper M; Donovan T; DeVries M
    J Am Coll Radiol; 2018 Jun; 15(6):900-904. PubMed ID: 29728326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involving Members of the Public in Health Economics Research: Insights from Selecting Health States for Valuation to Estimate Quality-Adjusted Life-Year (QALY) Weights.
    Goodwin E; Boddy K; Tatnell L; Hawton A
    Appl Health Econ Health Policy; 2018 Apr; 16(2):187-194. PubMed ID: 29047072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [People should be told unambiguously and clearly].
    Sygeplejersken; 1980 Jan; 80(2):3. PubMed ID: 6899553
    [No Abstract]   [Full Text] [Related]  

  • 9. From the Office of the General Counsel. When health care payers have market power.
    Ile ML
    JAMA; 1990 Apr; 263(14):1981-2, 1986. PubMed ID: 2313876
    [No Abstract]   [Full Text] [Related]  

  • 10. Insurance switching and mismatch between the costs and benefits of new technologies.
    Cutler D; Ciarametaro M; Long G; Kirson N; Dubois R
    Am J Manag Care; 2017 Dec; 23(12):750-757. PubMed ID: 29261241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deformed infants allowed to die due to medical costs, panel told.
    Auerbach S
    Washington Post; 1974 Jun; ():A3. PubMed ID: 11649110
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevalence, treatments and medical cost of multiple sclerosis in Japan based on analysis of a health insurance claims database.
    Ogino M; Okamoto S; Ohta H; Sakamoto M; Nakamura Y; Iwasaki K; Yoshida M; Hiroi S; Kawachi I
    Clin Exp Neuroimmunol; 2017 Nov; 8(4):318-326. PubMed ID: 29242717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Payers' Perspectives: Health Economics Outcomes in Managed Care.
    Bankhead C
    Am Health Drug Benefits; 2015 May; 8(3):144-7. PubMed ID: 26085902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The economics of Clostridium difficile-associated disease for providers and payers.
    Paladino JA; Schentag JJ
    Clin Infect Dis; 2008 Feb; 46(4):505-6. PubMed ID: 18197762
    [No Abstract]   [Full Text] [Related]  

  • 15. The Economics of Rheumatology Practice in the United States.
    Glaudemans J
    Rheum Dis Clin North Am; 2019 Feb; 45(1):1-12. PubMed ID: 30447738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Usability of databases in health economics].
    Brüggenjürgen B; Willich SN
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Jan; 49(1):11-8. PubMed ID: 16362135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The development of preferred provider organizations and its antitrust implications.
    Maram BS
    J Med Pract Manage; 1985 Oct; 1(2):130-5. PubMed ID: 10281825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can provider antitrust suits against payers be successful?
    Enders RJ
    Healthc Financ Manage; 1986 Jun; 40(6):72-80. PubMed ID: 10276682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of multiple sclerosis in Lebanon: A rising prevalence in the middle east.
    Zeineddine M; Hajje AA; Hussein A; El Ayoubi N; Yamout B
    Mult Scler Relat Disord; 2021 Jul; 52():102963. PubMed ID: 33934011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economics.
    Eisenberg JM
    JAMA; 1994 Jun; 271(21):1663-5. PubMed ID: 8182839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.